Gosogliptin
id:
gosogliptin-284-16837070
title:
Gosogliptin
text:
Gosogliptin is a drug for the treatment of type II diabetes. It is in the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It was discovered and developed through Phase 1 and Phase 2 by Pfizer. The crystal structure of DPP-4 in complex with gosogliptin is available. Its metabolism, excretion and pharmacokinetics in rat, dog and human have been described. A cost efficient route has been published. Other studies including Phase 3 studies were conducted in Russia. It is approved for use in Russi
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Gosogliptin
date created:
date modified:
2024-02-09T15:01:26Z
main entity:
{"identifier":"Q27077831","url":"https://www.wikidata.org/entity/Q27077831"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/54/Gosogliptin.svg","width":512,"height":225}
fields total:
13
integrity:
15